Found: 101
Select item for more details and to access through your institution.
Phase I/II trial of pyrazoloacridine and carboplatin in patients with recurrent glioma: A North Central Cancer Treatment Group trial.
- Published in:
- Investigational New Drugs, 2005, v. 23, n. 5, p. 495, doi. 10.1007/s10637-005-2910-4
- By:
- Publication type:
- Article
Adenoviral vectors expressing fusogenic membrane glycoproteins activated via matrix metalloproteinase cleavable linkers have significant antitumor potential in the gene therapy of gliomas.
- Published in:
- Journal of Gene Medicine, 2004, v. 6, n. 11, p. 1216, doi. 10.1002/jgm.616
- By:
- Publication type:
- Article
Personalizing Oncolytic Immunovirotherapy Approaches.
- Published in:
- Molecular Diagnosis & Therapy, 2024, v. 28, n. 2, p. 153, doi. 10.1007/s40291-023-00689-4
- By:
- Publication type:
- Article
Incorporation of Biomarker Assessment in Novel Clinical Trial Designs: Personalizing Brain Tumor Treatments.
- Published in:
- Current Oncology Reports, 2011, v. 13, n. 1, p. 42, doi. 10.1007/s11912-010-0144-x
- By:
- Publication type:
- Article
Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).
- Published in:
- 2019
- By:
- Publication type:
- Correction Notice
Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).
- Published in:
- Journal of Neuro-Oncology, 2019, v. 143, n. 3, p. 573, doi. 10.1007/s11060-019-03194-z
- By:
- Publication type:
- Article
Radiation-agent combinations for glioblastoma: challenges in drug development and future considerations.
- Published in:
- Journal of Neuro-Oncology, 2017, v. 134, n. 3, p. 551, doi. 10.1007/s11060-017-2458-0
- By:
- Publication type:
- Article
Total scapulectomy and constrained reverse total shoulder reconstruction for a Ewing's Sarcoma.
- Published in:
- Journal of Surgical Oncology, 2009, v. 100, n. 7, p. 611, doi. 10.1002/jso.21340
- By:
- Publication type:
- Article
Cancer: Tumour-fighting virus homes in.
- Published in:
- Nature, 2011, v. 477, n. 7362, p. 40, doi. 10.1038/477040a
- By:
- Publication type:
- Article
Inhibition of Cdk2 kinase activity selectively targets the CD44<sup>+</sup>/CD24<sup>-/Low</sup> stem-like subpopulation and restores chemosensitivity of SUM149PT triple-negative breast cancer cells.
- Published in:
- International Journal of Oncology, 2014, v. 45, n. 3, p. 1193, doi. 10.3892/ijo.2014.2523
- By:
- Publication type:
- Article
Examiner accuracy in cognitive testing in multisite brain-tumor clinical trials: an analysis from the Alliance for Clinical Trials in Oncology.
- Published in:
- Neuro-Oncology Practice, 2019, v. 6, n. 4, p. 283, doi. 10.1093/nop/npy048
- By:
- Publication type:
- Article
Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Applied Nanotechnology and Nanoscience in Orthopedic Oncology.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Extraskeletal Myxoid Chondrosarcoma of the Perineum.
- Published in:
- Orthopedics, 2009, v. 32, n. 3, p. 1, doi. 10.3928/01477447-20090301-20
- By:
- Publication type:
- Article
Advances and Challenges in Diagnosis and Management of Skeletal Metastases.
- Published in:
- Orthopedics, 2006, v. 29, n. 7, p. 609, doi. 10.3928/01477447-20060701-01
- By:
- Publication type:
- Article
Percutaneous osteoplasty for pelvic and spine metastases.
- Published in:
- 2006
- By:
- Publication type:
- journal article
Percutaneous Osteoplasty for Pelvic and Spine Metastases.
- Published in:
- Orthopedics, 2006, v. 29, n. 4, p. 316
- By:
- Publication type:
- Article
Minimally invasive techniques in orthopedic oncology: radiofrequency and laser thermal ablation.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Chordoma of the Spine: Clinicopathological Features, Diagnosis, and Treatment.
- Published in:
- Orthopedics, 2004, v. 27, n. 12, p. 1256, doi. 10.3928/0147-7447-20041201-14
- By:
- Publication type:
- Article
Primary Malignant Tumors of the Cervical Spine.
- Published in:
- Orthopedics, 2004, v. 27, n. 10, p. 1066, doi. 10.3928/0147-7447-20041001-16
- By:
- Publication type:
- Article
Erdheim-Chester disease.
- Published in:
- 2003
- By:
- Publication type:
- journal article
Phase II Trial of Intravenous Administration of Reolysin<sup>®</sup> (Reovirus Serotype-3-dearing Strain) in Patients with Metastatic Melanoma.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 10, p. 1998, doi. 10.1038/mt.2012.146
- By:
- Publication type:
- Article
Expression of Immunomodulatory Neutrophil-activating Protein of Helicobacter pylori Enhances the Antitumor Activity of Oncolytic Measles Virus.
- Published in:
- Molecular Therapy, 2012, v. 20, n. 6, p. 1139, doi. 10.1038/mt.2012.4
- By:
- Publication type:
- Article
Noninvasive Imaging and Radiovirotherapy of Prostate Cancer Using an Oncolytic Measles Virus Expressing the Sodium Iodide Symporter.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 12, p. 2041, doi. 10.1038/mt.2009.218
- By:
- Publication type:
- Article
Converting Tumor-specific Markers Into Reporters of Oncolytic Virus Infection.
- Published in:
- Molecular Therapy, 2009, v. 17, n. 8, p. 1395, doi. 10.1038/mt.2009.92
- By:
- Publication type:
- Article
Interleukin-13 Displaying Retargeted Oncolytic Measles Virus Strains Have Significant Activity Against Gliomas With Improved Specificity.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 9, p. 1556, doi. 10.1038/mt.2008.152
- By:
- Publication type:
- Article
Phase I Trial of a Pathotropic Retroviral Vector Expressing a Cytocidal Cyclin G1 Construct (Rexin-G) in Patients With Advanced Pancreatic Cancer.
- Published in:
- Molecular Therapy, 2008, v. 16, n. 5, p. 979, doi. 10.1038/mt.2008.29
- By:
- Publication type:
- Article
Epidermal Growth Factor Receptor (EGFR)–Retargeted Measles Virus Strains Effectively Target EGFR- or EGFRvIII Expressing Gliomas.
- Published in:
- Molecular Therapy, 2007, v. 15, n. 4, p. 677, doi. 10.1038/sj.mt.6300105
- By:
- Publication type:
- Article
44. Combination of Oncolytic Measles Virus Strains and Radiation Therapy Has Synergistic Activity in the Treatment of Glioblastoma Multiforme.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S19, doi. 10.1016/j.ymthe.2006.08.058
- By:
- Publication type:
- Article
297. Safety of Repeat Intracerebral Administration of MV-CEA in Rhesus Macaques in Support of a Phase I/II Clinical Trial for Patients with Recurrent Gliomas.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S113, doi. 10.1016/j.ymthe.2006.08.352
- By:
- Publication type:
- Article
430. EGFRvIII Retargeted Oncolytic Measles Virus Strains Have Significant Antitumor Activity Against Gliomas.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S165, doi. 10.1016/j.ymthe.2006.08.496
- By:
- Publication type:
- Article
729. Phase I Trial of Intraperitoneal (IP) Administration of a Measles Virus (MV) Strain Expressing the Human Carcinoembryonic Antigen (CEA) in Ovarian Cancer Patients.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S281, doi. 10.1016/j.ymthe.2006.08.809
- By:
- Publication type:
- Article
720. EGFRvIII Retargeted Oncolytic Measles Virus Strains Have Significant Antitumor Activity Against Gliomas
- Published in:
- 2005
- By:
- Publication type:
- Abstract
Constitutive Interferon Pathway Activation in Tumors as an Efficacy Determinant Following Oncolytic Virotherapy.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Aurora-A Kinase as a Promising Therapeutic Target in Cancer.
- Published in:
- Frontiers in Oncology, 2016, v. 5, p. 1, doi. 10.3389/fonc.2015.00295
- By:
- Publication type:
- Article
Incorporation of Prognostic and Predictive Factors Into Glioma Clinical Trials.
- Published in:
- Current Oncology Reports, 2013, v. 15, n. 1, p. 56, doi. 10.1007/s11912-012-0279-z
- By:
- Publication type:
- Article
MiR-31 and miR-128 regulates poliovirus receptor-related 4 mediated measles virus infectivity in tumors.
- Published in:
- Molecular Oncology, 2016, v. 10, n. 9, p. 1387, doi. 10.1016/j.molonc.2016.07.007
- By:
- Publication type:
- Article
Endogenous Heat-Shock Protein Induction with or Without Radiofrequency Ablation or Cryoablation in Patients with Stage IV Melanoma.
- Published in:
- Oncologist, 2017, v. 22, n. 9, p. 1026, doi. 10.1634/theoncologist.2017-0060
- By:
- Publication type:
- Article
Aurora-A Mitotic Kinase Induces Endocrine Resistance through Down-Regulation of ERα Expression in Initially ERα+ Breast Cancer Cells.
- Published in:
- PLoS ONE, 2014, v. 9, n. 5, p. 1, doi. 10.1371/journal.pone.0096995
- By:
- Publication type:
- Article
Targeting Src Family Kinases Inhibits Bevacizumab-Induced Glioma Cell Invasion.
- Published in:
- PLoS ONE, 2013, v. 8, n. 2, p. 1, doi. 10.1371/journal.pone.0056505
- By:
- Publication type:
- Article
Alliance A151945: Accrual and characteristics of adolescent and young adult patients in Alliance trials from 2000 to 2017.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 5, p. 750, doi. 10.1002/cncr.35078
- By:
- Publication type:
- Article
A phase 1 and randomized, placebo-controlled phase 2 trial of bevacizumab plus dasatinib in patients with recurrent glioblastoma: Alliance/North Central Cancer Treatment Group N0872.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Targeted treatment of papillary craniopharyngiomas harboring BRAF V600E mutations.
- Published in:
- 2019
- By:
- Publication type:
- case study
Optimizing patient derived mesenchymal stem cells as virus carriers for a Phase I clinical trial in ovarian cancer.
- Published in:
- Journal of Translational Medicine, 2013, v. 11, n. 1, p. 1, doi. 10.1186/1479-5876-11-20
- By:
- Publication type:
- Article
Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Phase 1/2 trial of temsirolimus and sorafenib in the treatment of patients with recurrent glioblastoma: North Central Cancer Treatment Group Study/Alliance N0572.
- Published in:
- 2018
- By:
- Publication type:
- journal article
High-dose Chemotherapy With Autologous Stem Cell Transplantation in Adults With Recurrent Embryonal Tumors of the Central Nervous System.
- Published in:
- Cancer (0008543X), 2008, v. 112, n. 8, p. 1805, doi. 10.1002/cncr.23362
- By:
- Publication type:
- Article
Immunostimulatory bacterial antigen-armed oncolytic measles virotherapy significantly increases the potency of anti-PD1 checkpoint therapy.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Phase I/randomized phase II trial of TRC105 plus bevacizumab versus bevacizumab in recurrent glioblastoma: North Central Cancer Treatment Group N1174 (Alliance).
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac041
- By:
- Publication type:
- Article
Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-023-43076-7
- By:
- Publication type:
- Article